1. Home /
  2. Analyst Actions

Analyst Actions

Okta Aims to Defend Lofty Valuation on Earnings

Okta Aims to Defend Lofty Valuation on Earnings

Outlining Okta's earnings prospects on Wednesday is a tale of tempting TAM and troublesome valuation.

Comcast Shares Resumed Outperform With $50 Target at Wells Fargo

Comcast Shares Resumed Outperform With $50 Target at Wells Fargo

Senior analyst Jennifer Fritzsche points out the company's diversified revenue base and calls the shares relatively cheap.

Zynga Gets Boost From Being Added to Wedbush's 'Best Ideas' List

Zynga Gets Boost From Being Added to Wedbush's 'Best Ideas' List

Shares of online gaming developer and provider Zynga get a boost after an analyst at Wedbush Securities adds the company to the firm's 'best ideas' list.

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Johnson & Johnson Rises on $572 Million Fine That's Smaller Than Feared

Wall Street expects the healthcare giant can take the jolt from the penalty delivered by an Oklahoma judge in the state's opioid case against J&J.

Amgen Adds Celgene's Otezla to Bolster Pipeline at Pricey Valuation

Amgen Adds Celgene's Otezla to Bolster Pipeline at Pricey Valuation

Amgen is finally making an expected splash out of its cash pile, but questions are abounding about the cost paid for Celgene's Otezla.

VMWare Drops Following Post-Deal Price-Target Cut

VMWare Drops Following Post-Deal Price-Target Cut

Shares of tech-security company VMWare drop after receiving a post-deal target price cut from Raymond James on what their analyst sees as moderating third-quarter sales.

Salesforce Stock Surges as Cloud King Status Is Cemented

Salesforce Stock Surges as Cloud King Status Is Cemented

Salesforce is characteristically sustaining strength despite a heap of headwinds.

Slack Stock Is Worth Picking Up, MKM Partners Analyst Says

Slack Stock Is Worth Picking Up, MKM Partners Analyst Says

Analyst Rohit Kulkarni initiates the San Francisco parent of the collaboration app at buy with a $40 price target, indicating 30% upside potential from Wednesday's close.

SolarEdge Shares Dim on Founder's Leave for Health Reasons

SolarEdge Shares Dim on Founder's Leave for Health Reasons

Solar-energy-tech provider's shares drop amid UBS stock downgrade and news that the founder and CEO has taken a leave of absence for a health issue.

Wall Street Is Skeptical of Nordstrom's Stock Surge

Wall Street Is Skeptical of Nordstrom's Stock Surge

Nordstrom may be nearing inflection but seeing is believing.